로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Vitronectin

Vitronectin

Brief Information

Name:Vitronectin
Target Synonym:Vitronectin,V75,VN,Serum-spreading factor,Vitronectin (Serum Spreading Factor, Somatomedin B, Complement S-Protein),Somatomedin B,Epibolin,Serum Spreading Factor,VNT,S-protein,Complement S-Protein,Protein S
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:0
Lastest Research Phase:Preclinical

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

VIN-H52H3-SPR
 Vitronectin SPR

Human ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag Free IT3-H52E3 (Cat. No. IT3-H52E3) immobilized on CM5 Chip can bind Human Vitronectin Protein, Tag Free (Cat. No. VIN-H52H3) with an affinity constant of 74.1 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

VIN-H52H3-ELISA
 Vitronectin ELISA

Immobilized Human Vitronectin Protein, Tag Free (Cat. No. VIN-H52H3) at 2 μg/mL (100 μL/well) can bind Human ITGAV&ITGB5 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT5-H52W5) with a linear range of 0.2-8 ng/mL (QC tested).

Synonym Name

VTN,V75,VN,Vitronectin,S-protein,Serum-spreading factor

Background

Vitronectin is also known as S-protein, VN, VTN, V75. Vitronectin, a multifunctional glycoprotein, is involved in coagulation, inhibition of the formation of the membrane attack complex (MAC), cell adhesion and migration, wound healing, and tissue remodeling. The primary cellular source of vitronectin is hepatocytes. Blocking of Hic(a member of the pneumococcal surface protein C (PspC) family) by specific antiserum or genetic deletion significantly reduced pneumococcal binding to soluble and immobilised vitronectin and to Factor H, respectively. In addition, Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.

Clinical and Translational Updates

This web search service is supported by Google Inc.

totop